2025 Billable ICD-10-CM Codes - Page 122

T48.0X1A - Poisoning by oxytocic drugs, accidental (unintentional), initial encounter Billable

T48.0X1D - Poisoning by oxytocic drugs, accidental (unintentional), subsequent encounter Billable

T48.0X1S - Poisoning by oxytocic drugs, accidental (unintentional), sequela Billable

T48.0X2A - Poisoning by oxytocic drugs, intentional self-harm, initial encounter Billable

T48.0X2D - Poisoning by oxytocic drugs, intentional self-harm, subsequent encounter Billable

T48.0X2S - Poisoning by oxytocic drugs, intentional self-harm, sequela Billable

T48.0X3A - Poisoning by oxytocic drugs, assault, initial encounter Billable

T48.0X3D - Poisoning by oxytocic drugs, assault, subsequent encounter Billable

T48.0X3S - Poisoning by oxytocic drugs, assault, sequela Billable

T48.0X4A - Poisoning by oxytocic drugs, undetermined, initial encounter Billable

T48.0X4D - Poisoning by oxytocic drugs, undetermined, subsequent encounter Billable

T48.0X4S - Poisoning by oxytocic drugs, undetermined, sequela Billable

T48.0X5A - Adverse effect of oxytocic drugs, initial encounter Billable

T48.0X5D - Adverse effect of oxytocic drugs, subsequent encounter Billable

T48.0X5S - Adverse effect of oxytocic drugs, sequela Billable

T48.0X6A - Underdosing of oxytocic drugs, initial encounter Billable

T48.0X6D - Underdosing of oxytocic drugs, subsequent encounter Billable

T48.0X6S - Underdosing of oxytocic drugs, sequela Billable

T48.1X1A - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), initial encounter Billable

T48.1X1D - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), subsequent encounter Billable

T48.1X1S - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], accidental (unintentional), sequela Billable

T48.1X2A - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, initial encounter Billable

T48.1X2D - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, subsequent encounter Billable

T48.1X2S - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], intentional self-harm, sequela Billable

T48.1X3A - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, initial encounter Billable

T48.1X3D - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, subsequent encounter Billable

T48.1X3S - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], assault, sequela Billable

T48.1X4A - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, initial encounter Billable

T48.1X4D - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, subsequent encounter Billable

T48.1X4S - Poisoning by skeletal muscle relaxants [neuromuscular blocking agents], undetermined, sequela Billable

T48.1X5A - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter Billable

T48.1X5D - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter Billable

T48.1X5S - Adverse effect of skeletal muscle relaxants [neuromuscular blocking agents], sequela Billable

T48.1X6A - Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], initial encounter Billable

T48.1X6D - Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], subsequent encounter Billable

T48.1X6S - Underdosing of skeletal muscle relaxants [neuromuscular blocking agents], sequela Billable

T48.201A - Poisoning by unspecified drugs acting on muscles, accidental (unintentional), initial encounter Billable

T48.201D - Poisoning by unspecified drugs acting on muscles, accidental (unintentional), subsequent encounter Billable

T48.201S - Poisoning by unspecified drugs acting on muscles, accidental (unintentional), sequela Billable

T48.202A - Poisoning by unspecified drugs acting on muscles, intentional self-harm, initial encounter Billable

T48.202D - Poisoning by unspecified drugs acting on muscles, intentional self-harm, subsequent encounter Billable

T48.202S - Poisoning by unspecified drugs acting on muscles, intentional self-harm, sequela Billable

T48.203A - Poisoning by unspecified drugs acting on muscles, assault, initial encounter Billable

T48.203D - Poisoning by unspecified drugs acting on muscles, assault, subsequent encounter Billable

T48.203S - Poisoning by unspecified drugs acting on muscles, assault, sequela Billable

T48.204A - Poisoning by unspecified drugs acting on muscles, undetermined, initial encounter Billable

T48.204D - Poisoning by unspecified drugs acting on muscles, undetermined, subsequent encounter Billable

T48.204S - Poisoning by unspecified drugs acting on muscles, undetermined, sequela Billable

T48.205A - Adverse effect of unspecified drugs acting on muscles, initial encounter Billable

T48.205D - Adverse effect of unspecified drugs acting on muscles, subsequent encounter Billable

T48.205S - Adverse effect of unspecified drugs acting on muscles, sequela Billable

T48.206A - Underdosing of unspecified drugs acting on muscles, initial encounter Billable

T48.206D - Underdosing of unspecified drugs acting on muscles, subsequent encounter Billable

T46.0X1A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter Billable

T46.0X1D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter Billable

T46.0X1S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela Billable

T46.0X2A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter Billable

T46.0X2D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter Billable

T46.0X2S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela Billable

T46.0X3A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter Billable

T46.0X3D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter Billable

T46.0X3S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela Billable

T46.0X4A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter Billable

T46.0X4D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter Billable

T46.0X4S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela Billable

T46.0X5A - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter Billable

T46.0X5D - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter Billable

T46.0X5S - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela Billable

T46.0X6A - Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter Billable

T46.0X6D - Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter Billable

T46.0X6S - Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela Billable

T46.1X1A - Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter Billable

T46.1X1D - Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter Billable

T46.1X1S - Poisoning by calcium-channel blockers, accidental (unintentional), sequela Billable

T46.1X2A - Poisoning by calcium-channel blockers, intentional self-harm, initial encounter Billable

T46.1X2D - Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter Billable

T46.1X2S - Poisoning by calcium-channel blockers, intentional self-harm, sequela Billable

T46.1X3A - Poisoning by calcium-channel blockers, assault, initial encounter Billable

T46.1X3D - Poisoning by calcium-channel blockers, assault, subsequent encounter Billable

T46.1X3S - Poisoning by calcium-channel blockers, assault, sequela Billable

T46.1X4A - Poisoning by calcium-channel blockers, undetermined, initial encounter Billable

T46.1X4D - Poisoning by calcium-channel blockers, undetermined, subsequent encounter Billable

T46.1X4S - Poisoning by calcium-channel blockers, undetermined, sequela Billable

T46.1X5A - Adverse effect of calcium-channel blockers, initial encounter Billable

T46.1X5D - Adverse effect of calcium-channel blockers, subsequent encounter Billable

T46.1X5S - Adverse effect of calcium-channel blockers, sequela Billable

T46.1X6A - Underdosing of calcium-channel blockers, initial encounter Billable

T46.1X6D - Underdosing of calcium-channel blockers, subsequent encounter Billable

T46.1X6S - Underdosing of calcium-channel blockers, sequela Billable

T46.2X1A - Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter Billable

T46.2X1D - Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter Billable

T46.2X1S - Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela Billable

T46.2X2A - Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter Billable

T46.2X2D - Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter Billable

T46.2X2S - Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela Billable

T46.2X3A - Poisoning by other antidysrhythmic drugs, assault, initial encounter Billable

T46.2X3D - Poisoning by other antidysrhythmic drugs, assault, subsequent encounter Billable

T46.2X3S - Poisoning by other antidysrhythmic drugs, assault, sequela Billable

T46.2X4A - Poisoning by other antidysrhythmic drugs, undetermined, initial encounter Billable

T46.2X4D - Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter Billable

T46.2X4S - Poisoning by other antidysrhythmic drugs, undetermined, sequela Billable

T46.2X5A - Adverse effect of other antidysrhythmic drugs, initial encounter Billable

T46.2X5D - Adverse effect of other antidysrhythmic drugs, subsequent encounter Billable

T46.2X5S - Adverse effect of other antidysrhythmic drugs, sequela Billable

T46.2X6A - Underdosing of other antidysrhythmic drugs, initial encounter Billable

T46.2X6D - Underdosing of other antidysrhythmic drugs, subsequent encounter Billable

T46.2X6S - Underdosing of other antidysrhythmic drugs, sequela Billable

T46.3X1A - Poisoning by coronary vasodilators, accidental (unintentional), initial encounter Billable

T46.3X1D - Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter Billable

T46.3X1S - Poisoning by coronary vasodilators, accidental (unintentional), sequela Billable

T46.3X2A - Poisoning by coronary vasodilators, intentional self-harm, initial encounter Billable

T46.3X2D - Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter Billable

T46.3X2S - Poisoning by coronary vasodilators, intentional self-harm, sequela Billable

T46.3X3A - Poisoning by coronary vasodilators, assault, initial encounter Billable

T46.3X3D - Poisoning by coronary vasodilators, assault, subsequent encounter Billable

T46.3X3S - Poisoning by coronary vasodilators, assault, sequela Billable

T46.3X4A - Poisoning by coronary vasodilators, undetermined, initial encounter Billable

T46.3X4D - Poisoning by coronary vasodilators, undetermined, subsequent encounter Billable

T46.3X4S - Poisoning by coronary vasodilators, undetermined, sequela Billable

T46.3X5A - Adverse effect of coronary vasodilators, initial encounter Billable

T46.3X5D - Adverse effect of coronary vasodilators, subsequent encounter Billable

T46.3X5S - Adverse effect of coronary vasodilators, sequela Billable

T46.3X6A - Underdosing of coronary vasodilators, initial encounter Billable

T46.3X6D - Underdosing of coronary vasodilators, subsequent encounter Billable

T46.3X6S - Underdosing of coronary vasodilators, sequela Billable

T46.4X1A - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter Billable

T46.4X1D - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter Billable

T46.4X1S - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela Billable

T46.4X2A - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter Billable

T46.4X2D - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter Billable

T46.4X2S - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela Billable

T46.4X3A - Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter Billable

T46.4X3D - Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter Billable

T46.4X3S - Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela Billable

T46.4X4A - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter Billable

T46.4X4D - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter Billable

T46.4X4S - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela Billable

T46.4X5A - Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter Billable

T46.4X5D - Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter Billable

T46.4X5S - Adverse effect of angiotensin-converting-enzyme inhibitors, sequela Billable

T46.4X6A - Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter Billable

T46.4X6D - Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter Billable

T46.4X6S - Underdosing of angiotensin-converting-enzyme inhibitors, sequela Billable

T46.5X1A - Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter Billable

T46.5X1D - Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter Billable

T46.5X1S - Poisoning by other antihypertensive drugs, accidental (unintentional), sequela Billable

T46.5X2A - Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter Billable

T46.5X2D - Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter Billable

T46.5X2S - Poisoning by other antihypertensive drugs, intentional self-harm, sequela Billable

T46.5X3A - Poisoning by other antihypertensive drugs, assault, initial encounter Billable

T46.5X3D - Poisoning by other antihypertensive drugs, assault, subsequent encounter Billable

T46.5X3S - Poisoning by other antihypertensive drugs, assault, sequela Billable

T46.5X4A - Poisoning by other antihypertensive drugs, undetermined, initial encounter Billable

T46.5X4D - Poisoning by other antihypertensive drugs, undetermined, subsequent encounter Billable

T46.5X4S - Poisoning by other antihypertensive drugs, undetermined, sequela Billable

T46.5X5A - Adverse effect of other antihypertensive drugs, initial encounter Billable

T46.5X5D - Adverse effect of other antihypertensive drugs, subsequent encounter Billable

T46.5X5S - Adverse effect of other antihypertensive drugs, sequela Billable

T46.5X6A - Underdosing of other antihypertensive drugs, initial encounter Billable

T46.5X6D - Underdosing of other antihypertensive drugs, subsequent encounter Billable

T46.5X6S - Underdosing of other antihypertensive drugs, sequela Billable

T46.6X1A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter Billable

T46.6X1D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter Billable

T46.6X1S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela Billable

T46.6X2A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter Billable

T46.6X2D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter Billable

T46.6X2S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela Billable

T46.6X3A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter Billable

T46.6X3D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter Billable

T46.6X3S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela Billable

T46.6X4A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter Billable

T46.6X4D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter Billable

T46.6X4S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela Billable

T46.6X5A - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter Billable

T46.6X5D - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter Billable

T46.6X5S - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela Billable

T46.6X6A - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter Billable

T46.6X6D - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter Billable

T46.6X6S - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela Billable

T46.7X1A - Poisoning by peripheral vasodilators, accidental (unintentional), initial encounter Billable

T46.7X1D - Poisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter Billable

T46.7X1S - Poisoning by peripheral vasodilators, accidental (unintentional), sequela Billable

T46.7X2A - Poisoning by peripheral vasodilators, intentional self-harm, initial encounter Billable

T46.7X2D - Poisoning by peripheral vasodilators, intentional self-harm, subsequent encounter Billable

T46.7X2S - Poisoning by peripheral vasodilators, intentional self-harm, sequela Billable

T46.7X3A - Poisoning by peripheral vasodilators, assault, initial encounter Billable

T46.7X3D - Poisoning by peripheral vasodilators, assault, subsequent encounter Billable

T46.7X3S - Poisoning by peripheral vasodilators, assault, sequela Billable

T46.7X4A - Poisoning by peripheral vasodilators, undetermined, initial encounter Billable

T46.7X4D - Poisoning by peripheral vasodilators, undetermined, subsequent encounter Billable

T46.7X4S - Poisoning by peripheral vasodilators, undetermined, sequela Billable

T46.7X5A - Adverse effect of peripheral vasodilators, initial encounter Billable

T46.7X5D - Adverse effect of peripheral vasodilators, subsequent encounter Billable

T46.7X5S - Adverse effect of peripheral vasodilators, sequela Billable

T46.7X6A - Underdosing of peripheral vasodilators, initial encounter Billable

T46.7X6D - Underdosing of peripheral vasodilators, subsequent encounter Billable

T46.7X6S - Underdosing of peripheral vasodilators, sequela Billable

T46.8X1A - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter Billable

T46.8X1D - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter Billable

T46.8X1S - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela Billable

T46.8X2A - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter Billable

T46.8X2D - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter Billable

T46.8X2S - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela Billable

T46.8X3A - Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter Billable

T46.8X3D - Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter Billable

T46.8X3S - Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela Billable

T46.8X4A - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter Billable

T46.8X4D - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter Billable

T46.8X4S - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela Billable

T46.8X5A - Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter Billable

T46.8X5D - Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter Billable

T46.8X5S - Adverse effect of antivaricose drugs, including sclerosing agents, sequela Billable

T46.8X6A - Underdosing of antivaricose drugs, including sclerosing agents, initial encounter Billable

T46.8X6D - Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter Billable

T46.8X6S - Underdosing of antivaricose drugs, including sclerosing agents, sequela Billable

T46.901A - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter Billable

T46.901D - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter Billable

T46.901S - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela Billable

T46.902A - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter Billable

T46.902D - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter Billable

T46.902S - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela Billable

T46.903A - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter Billable

T46.903D - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter Billable

T46.903S - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela Billable

T46.904A - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter Billable

T46.904D - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter Billable

T46.904S - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela Billable

T46.905A - Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter Billable

T46.905D - Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter Billable

T46.905S - Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela Billable

T46.906A - Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter Billable

T46.906D - Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter Billable

T46.906S - Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela Billable

T46.991A - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter Billable

T46.991D - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter Billable

T46.991S - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela Billable

T46.992A - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter Billable

T46.992D - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter Billable

T46.992S - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela Billable

T46.993A - Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter Billable

T46.993D - Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter Billable

T46.993S - Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela Billable

T46.994A - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter Billable

T46.994D - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter Billable

T46.994S - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela Billable

T46.995A - Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter Billable

T46.995D - Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter Billable

T46.995S - Adverse effect of other agents primarily affecting the cardiovascular system, sequela Billable

T46.996A - Underdosing of other agents primarily affecting the cardiovascular system, initial encounter Billable

T46.996D - Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter Billable

T46.996S - Underdosing of other agents primarily affecting the cardiovascular system, sequela Billable

T47.0X1A - Poisoning by histamine H2-receptor blockers, accidental (unintentional), initial encounter Billable

T47.0X1D - Poisoning by histamine H2-receptor blockers, accidental (unintentional), subsequent encounter Billable

T47.0X1S - Poisoning by histamine H2-receptor blockers, accidental (unintentional), sequela Billable

T47.0X2A - Poisoning by histamine H2-receptor blockers, intentional self-harm, initial encounter Billable

T47.0X2D - Poisoning by histamine H2-receptor blockers, intentional self-harm, subsequent encounter Billable

T47.0X2S - Poisoning by histamine H2-receptor blockers, intentional self-harm, sequela Billable

T47.0X3A - Poisoning by histamine H2-receptor blockers, assault, initial encounter Billable

T47.0X3D - Poisoning by histamine H2-receptor blockers, assault, subsequent encounter Billable

T47.0X3S - Poisoning by histamine H2-receptor blockers, assault, sequela Billable

T47.0X4A - Poisoning by histamine H2-receptor blockers, undetermined, initial encounter Billable

T47.0X4D - Poisoning by histamine H2-receptor blockers, undetermined, subsequent encounter Billable

T47.0X4S - Poisoning by histamine H2-receptor blockers, undetermined, sequela Billable

T47.0X5A - Adverse effect of histamine H2-receptor blockers, initial encounter Billable

T47.0X5D - Adverse effect of histamine H2-receptor blockers, subsequent encounter Billable

T47.0X5S - Adverse effect of histamine H2-receptor blockers, sequela Billable

T47.0X6A - Underdosing of histamine H2-receptor blockers, initial encounter Billable

T47.0X6D - Underdosing of histamine H2-receptor blockers, subsequent encounter Billable

T47.0X6S - Underdosing of histamine H2-receptor blockers, sequela Billable

T47.1X1A - Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), initial encounter Billable

T47.1X1D - Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), subsequent encounter Billable

T47.1X1S - Poisoning by other antacids and anti-gastric-secretion drugs, accidental (unintentional), sequela Billable

T47.1X2A - Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, initial encounter Billable

T47.1X2D - Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, subsequent encounter Billable

T47.1X2S - Poisoning by other antacids and anti-gastric-secretion drugs, intentional self-harm, sequela Billable

T47.1X3A - Poisoning by other antacids and anti-gastric-secretion drugs, assault, initial encounter Billable

T47.1X3D - Poisoning by other antacids and anti-gastric-secretion drugs, assault, subsequent encounter Billable

T47.1X3S - Poisoning by other antacids and anti-gastric-secretion drugs, assault, sequela Billable

T47.1X4A - Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, initial encounter Billable

T47.1X4D - Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, subsequent encounter Billable

T47.1X4S - Poisoning by other antacids and anti-gastric-secretion drugs, undetermined, sequela Billable

T47.1X5A - Adverse effect of other antacids and anti-gastric-secretion drugs, initial encounter Billable

T47.1X5D - Adverse effect of other antacids and anti-gastric-secretion drugs, subsequent encounter Billable

T47.1X5S - Adverse effect of other antacids and anti-gastric-secretion drugs, sequela Billable

T47.1X6A - Underdosing of other antacids and anti-gastric-secretion drugs, initial encounter Billable

T47.1X6D - Underdosing of other antacids and anti-gastric-secretion drugs, subsequent encounter Billable

T47.1X6S - Underdosing of other antacids and anti-gastric-secretion drugs, sequela Billable

T47.2X1A - Poisoning by stimulant laxatives, accidental (unintentional), initial encounter Billable

T47.2X1D - Poisoning by stimulant laxatives, accidental (unintentional), subsequent encounter Billable

T47.2X1S - Poisoning by stimulant laxatives, accidental (unintentional), sequela Billable

T47.2X2A - Poisoning by stimulant laxatives, intentional self-harm, initial encounter Billable

T47.2X2D - Poisoning by stimulant laxatives, intentional self-harm, subsequent encounter Billable

T47.2X2S - Poisoning by stimulant laxatives, intentional self-harm, sequela Billable

T47.2X3A - Poisoning by stimulant laxatives, assault, initial encounter Billable

T47.2X3D - Poisoning by stimulant laxatives, assault, subsequent encounter Billable

T47.2X3S - Poisoning by stimulant laxatives, assault, sequela Billable

T47.2X4A - Poisoning by stimulant laxatives, undetermined, initial encounter Billable

T47.2X4D - Poisoning by stimulant laxatives, undetermined, subsequent encounter Billable

T47.2X4S - Poisoning by stimulant laxatives, undetermined, sequela Billable

T47.2X5A - Adverse effect of stimulant laxatives, initial encounter Billable

T47.2X5D - Adverse effect of stimulant laxatives, subsequent encounter Billable

T47.2X5S - Adverse effect of stimulant laxatives, sequela Billable

T47.2X6A - Underdosing of stimulant laxatives, initial encounter Billable

T47.2X6D - Underdosing of stimulant laxatives, subsequent encounter Billable

T47.2X6S - Underdosing of stimulant laxatives, sequela Billable

T47.3X1A - Poisoning by saline and osmotic laxatives, accidental (unintentional), initial encounter Billable

T47.3X1D - Poisoning by saline and osmotic laxatives, accidental (unintentional), subsequent encounter Billable

T47.3X1S - Poisoning by saline and osmotic laxatives, accidental (unintentional), sequela Billable

T47.3X2A - Poisoning by saline and osmotic laxatives, intentional self-harm, initial encounter Billable

T47.3X2D - Poisoning by saline and osmotic laxatives, intentional self-harm, subsequent encounter Billable

T47.3X2S - Poisoning by saline and osmotic laxatives, intentional self-harm, sequela Billable

T47.3X3A - Poisoning by saline and osmotic laxatives, assault, initial encounter Billable

T47.3X3D - Poisoning by saline and osmotic laxatives, assault, subsequent encounter Billable

T47.3X3S - Poisoning by saline and osmotic laxatives, assault, sequela Billable

T47.3X4A - Poisoning by saline and osmotic laxatives, undetermined, initial encounter Billable

T47.3X4D - Poisoning by saline and osmotic laxatives, undetermined, subsequent encounter Billable

T47.3X4S - Poisoning by saline and osmotic laxatives, undetermined, sequela Billable

T47.3X5A - Adverse effect of saline and osmotic laxatives, initial encounter Billable

T47.3X5D - Adverse effect of saline and osmotic laxatives, subsequent encounter Billable

T47.3X5S - Adverse effect of saline and osmotic laxatives, sequela Billable

T47.3X6A - Underdosing of saline and osmotic laxatives, initial encounter Billable

T47.3X6D - Underdosing of saline and osmotic laxatives, subsequent encounter Billable

T47.3X6S - Underdosing of saline and osmotic laxatives, sequela Billable

T47.4X1A - Poisoning by other laxatives, accidental (unintentional), initial encounter Billable

T47.4X1D - Poisoning by other laxatives, accidental (unintentional), subsequent encounter Billable

T47.4X1S - Poisoning by other laxatives, accidental (unintentional), sequela Billable

T47.4X2A - Poisoning by other laxatives, intentional self-harm, initial encounter Billable

T47.4X2D - Poisoning by other laxatives, intentional self-harm, subsequent encounter Billable

T47.4X2S - Poisoning by other laxatives, intentional self-harm, sequela Billable

T47.4X3A - Poisoning by other laxatives, assault, initial encounter Billable

T47.4X3D - Poisoning by other laxatives, assault, subsequent encounter Billable

T47.4X3S - Poisoning by other laxatives, assault, sequela Billable

T47.4X4A - Poisoning by other laxatives, undetermined, initial encounter Billable

T47.4X4D - Poisoning by other laxatives, undetermined, subsequent encounter Billable

T47.4X4S - Poisoning by other laxatives, undetermined, sequela Billable

T47.4X5A - Adverse effect of other laxatives, initial encounter Billable

T47.4X5D - Adverse effect of other laxatives, subsequent encounter Billable

T47.4X5S - Adverse effect of other laxatives, sequela Billable

T47.4X6A - Underdosing of other laxatives, initial encounter Billable

T47.4X6D - Underdosing of other laxatives, subsequent encounter Billable

T47.4X6S - Underdosing of other laxatives, sequela Billable

T47.5X1A - Poisoning by digestants, accidental (unintentional), initial encounter Billable

T47.5X1D - Poisoning by digestants, accidental (unintentional), subsequent encounter Billable

T47.5X1S - Poisoning by digestants, accidental (unintentional), sequela Billable

T47.5X2A - Poisoning by digestants, intentional self-harm, initial encounter Billable

T47.5X2D - Poisoning by digestants, intentional self-harm, subsequent encounter Billable

T47.5X2S - Poisoning by digestants, intentional self-harm, sequela Billable

T47.5X3A - Poisoning by digestants, assault, initial encounter Billable

T47.5X3D - Poisoning by digestants, assault, subsequent encounter Billable

T47.5X3S - Poisoning by digestants, assault, sequela Billable

T47.5X4A - Poisoning by digestants, undetermined, initial encounter Billable

T47.5X4D - Poisoning by digestants, undetermined, subsequent encounter Billable

T47.5X4S - Poisoning by digestants, undetermined, sequela Billable

T47.5X5A - Adverse effect of digestants, initial encounter Billable

T47.5X5D - Adverse effect of digestants, subsequent encounter Billable

T47.5X5S - Adverse effect of digestants, sequela Billable

T47.5X6A - Underdosing of digestants, initial encounter Billable

T47.5X6D - Underdosing of digestants, subsequent encounter Billable

T47.5X6S - Underdosing of digestants, sequela Billable

T47.6X1A - Poisoning by antidiarrheal drugs, accidental (unintentional), initial encounter Billable

T47.6X1D - Poisoning by antidiarrheal drugs, accidental (unintentional), subsequent encounter Billable

T47.6X1S - Poisoning by antidiarrheal drugs, accidental (unintentional), sequela Billable

T47.6X2A - Poisoning by antidiarrheal drugs, intentional self-harm, initial encounter Billable

T47.6X2D - Poisoning by antidiarrheal drugs, intentional self-harm, subsequent encounter Billable

T47.6X2S - Poisoning by antidiarrheal drugs, intentional self-harm, sequela Billable

T47.6X3A - Poisoning by antidiarrheal drugs, assault, initial encounter Billable

T47.6X3D - Poisoning by antidiarrheal drugs, assault, subsequent encounter Billable

T47.6X3S - Poisoning by antidiarrheal drugs, assault, sequela Billable

T47.6X4A - Poisoning by antidiarrheal drugs, undetermined, initial encounter Billable

T47.6X4D - Poisoning by antidiarrheal drugs, undetermined, subsequent encounter Billable

T47.6X4S - Poisoning by antidiarrheal drugs, undetermined, sequela Billable

T47.6X5A - Adverse effect of antidiarrheal drugs, initial encounter Billable

T47.6X5D - Adverse effect of antidiarrheal drugs, subsequent encounter Billable

T47.6X5S - Adverse effect of antidiarrheal drugs, sequela Billable

T47.6X6A - Underdosing of antidiarrheal drugs, initial encounter Billable

T47.6X6D - Underdosing of antidiarrheal drugs, subsequent encounter Billable

T47.6X6S - Underdosing of antidiarrheal drugs, sequela Billable

T47.7X1A - Poisoning by emetics, accidental (unintentional), initial encounter Billable

T47.7X1D - Poisoning by emetics, accidental (unintentional), subsequent encounter Billable

T47.7X1S - Poisoning by emetics, accidental (unintentional), sequela Billable

T47.7X2A - Poisoning by emetics, intentional self-harm, initial encounter Billable

T47.7X2D - Poisoning by emetics, intentional self-harm, subsequent encounter Billable

T47.7X2S - Poisoning by emetics, intentional self-harm, sequela Billable

T47.7X3A - Poisoning by emetics, assault, initial encounter Billable

T47.7X3D - Poisoning by emetics, assault, subsequent encounter Billable

T47.7X3S - Poisoning by emetics, assault, sequela Billable

T47.7X4A - Poisoning by emetics, undetermined, initial encounter Billable

T47.7X4D - Poisoning by emetics, undetermined, subsequent encounter Billable

T47.7X4S - Poisoning by emetics, undetermined, sequela Billable

T47.7X5A - Adverse effect of emetics, initial encounter Billable

T47.7X5D - Adverse effect of emetics, subsequent encounter Billable

T47.7X5S - Adverse effect of emetics, sequela Billable

T47.7X6A - Underdosing of emetics, initial encounter Billable

T47.7X6D - Underdosing of emetics, subsequent encounter Billable

T47.7X6S - Underdosing of emetics, sequela Billable

T47.8X1A - Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), initial encounter Billable

T47.8X1D - Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), subsequent encounter Billable

T47.8X1S - Poisoning by other agents primarily affecting gastrointestinal system, accidental (unintentional), sequela Billable

T47.8X2A - Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, initial encounter Billable

T47.8X2D - Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, subsequent encounter Billable

T47.8X2S - Poisoning by other agents primarily affecting gastrointestinal system, intentional self-harm, sequela Billable

T47.8X3A - Poisoning by other agents primarily affecting gastrointestinal system, assault, initial encounter Billable

T47.8X3D - Poisoning by other agents primarily affecting gastrointestinal system, assault, subsequent encounter Billable

T47.8X3S - Poisoning by other agents primarily affecting gastrointestinal system, assault, sequela Billable

T47.8X4A - Poisoning by other agents primarily affecting gastrointestinal system, undetermined, initial encounter Billable

T47.8X4D - Poisoning by other agents primarily affecting gastrointestinal system, undetermined, subsequent encounter Billable

T47.8X4S - Poisoning by other agents primarily affecting gastrointestinal system, undetermined, sequela Billable

T47.8X5A - Adverse effect of other agents primarily affecting gastrointestinal system, initial encounter Billable

T47.8X5D - Adverse effect of other agents primarily affecting gastrointestinal system, subsequent encounter Billable

T47.8X5S - Adverse effect of other agents primarily affecting gastrointestinal system, sequela Billable

T47.8X6A - Underdosing of other agents primarily affecting gastrointestinal system, initial encounter Billable

T47.8X6D - Underdosing of other agents primarily affecting gastrointestinal system, subsequent encounter Billable

T47.8X6S - Underdosing of other agents primarily affecting gastrointestinal system, sequela Billable

T47.91XA - Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), initial encounter Billable

T47.91XD - Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), subsequent encounter Billable

T47.91XS - Poisoning by unspecified agents primarily affecting the gastrointestinal system, accidental (unintentional), sequela Billable

T47.92XA - Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, initial encounter Billable

T47.92XD - Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, subsequent encounter Billable

T47.92XS - Poisoning by unspecified agents primarily affecting the gastrointestinal system, intentional self-harm, sequela Billable

T47.93XA - Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault, initial encounter Billable

T47.93XD - Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault, subsequent encounter Billable

T47.93XS - Poisoning by unspecified agents primarily affecting the gastrointestinal system, assault, sequela Billable

T47.94XA - Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, initial encounter Billable

T47.94XD - Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, subsequent encounter Billable

T47.94XS - Poisoning by unspecified agents primarily affecting the gastrointestinal system, undetermined, sequela Billable

T47.95XA - Adverse effect of unspecified agents primarily affecting the gastrointestinal system, initial encounter Billable

T47.95XD - Adverse effect of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter Billable

T47.95XS - Adverse effect of unspecified agents primarily affecting the gastrointestinal system, sequela Billable

T47.96XA - Underdosing of unspecified agents primarily affecting the gastrointestinal system, initial encounter Billable

T47.96XD - Underdosing of unspecified agents primarily affecting the gastrointestinal system, subsequent encounter Billable

T47.96XS - Underdosing of unspecified agents primarily affecting the gastrointestinal system, sequela Billable

T45.7X2A - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter Billable

T45.7X2D - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter Billable

T45.7X2S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela Billable

T45.7X3A - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, initial encounter Billable

T45.7X3D - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter Billable

T45.7X3S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, sequela Billable

T45.7X4A - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, initial encounter Billable

T45.7X4D - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter Billable

T45.7X4S - Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, sequela Billable

T45.7X5A - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, initial encounter Billable

T45.7X5D - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter Billable

T45.7X5S - Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, sequela Billable

T45.7X6A - Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter Billable

T45.7X6D - Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter Billable

T45.7X6S - Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela Billable

T45.8X1A - Poisoning by other primarily systemic and hematological agents, accidental (unintentional), initial encounter Billable

T45.8X1D - Poisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter Billable

T45.8X1S - Poisoning by other primarily systemic and hematological agents, accidental (unintentional), sequela Billable

T45.8X2A - Poisoning by other primarily systemic and hematological agents, intentional self-harm, initial encounter Billable

T45.8X2D - Poisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter Billable

T45.8X2S - Poisoning by other primarily systemic and hematological agents, intentional self-harm, sequela Billable

T45.8X3A - Poisoning by other primarily systemic and hematological agents, assault, initial encounter Billable

T45.8X3D - Poisoning by other primarily systemic and hematological agents, assault, subsequent encounter Billable

T45.8X3S - Poisoning by other primarily systemic and hematological agents, assault, sequela Billable

T45.8X4A - Poisoning by other primarily systemic and hematological agents, undetermined, initial encounter Billable

T45.8X4D - Poisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter Billable

T45.8X4S - Poisoning by other primarily systemic and hematological agents, undetermined, sequela Billable

T45.8X5A - Adverse effect of other primarily systemic and hematological agents, initial encounter Billable

T45.8X5D - Adverse effect of other primarily systemic and hematological agents, subsequent encounter Billable

T45.8X5S - Adverse effect of other primarily systemic and hematological agents, sequela Billable

T45.8X6A - Underdosing of other primarily systemic and hematological agents, initial encounter Billable

T45.8X6D - Underdosing of other primarily systemic and hematological agents, subsequent encounter Billable

T45.8X6S - Underdosing of other primarily systemic and hematological agents, sequela Billable

T45.91XA - Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), initial encounter Billable

T45.91XD - Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter Billable

T45.91XS - Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), sequela Billable

T45.92XA - Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, initial encounter Billable

T45.92XD - Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter Billable

T45.92XS - Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, sequela Billable

T45.93XA - Poisoning by unspecified primarily systemic and hematological agent, assault, initial encounter Billable

T45.93XD - Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter Billable

T45.93XS - Poisoning by unspecified primarily systemic and hematological agent, assault, sequela Billable

T45.94XA - Poisoning by unspecified primarily systemic and hematological agent, undetermined, initial encounter Billable

T45.94XD - Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter Billable

T45.94XS - Poisoning by unspecified primarily systemic and hematological agent, undetermined, sequela Billable

T45.95XA - Adverse effect of unspecified primarily systemic and hematological agent, initial encounter Billable

T45.95XD - Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter Billable

T45.95XS - Adverse effect of unspecified primarily systemic and hematological agent, sequela Billable

T45.96XA - Underdosing of unspecified primarily systemic and hematological agent, initial encounter Billable

T45.96XD - Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter Billable

T45.96XS - Underdosing of unspecified primarily systemic and hematological agent, sequela Billable

T45.AX1A - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), initial encounter Billable

T45.AX1D - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounter Billable

T45.AX1S - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequela Billable

T45.AX2A - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounter Billable

T45.AX2D - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounter Billable

T45.AX2S - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequela Billable

T45.AX3A - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounter Billable

T45.AX3D - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounter Billable

T45.AX3S - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela Billable

T45.AX4A - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, initial encounter Billable

T45.AX4D - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounter Billable

T45.AX4S - Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, sequela Billable

T45.AX5A - Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter Billable

T45.AX5D - Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter Billable

T45.AX5S - Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela Billable

T45.AX6A - Underdosing of immune checkpoint inhibitors and immunostimulant drugs, initial encounter Billable

T45.AX6D - Underdosing of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter Billable

T45.AX6S - Underdosing of immune checkpoint inhibitors and immunostimulant drugs, sequela Billable